EZH2 and breast cancer: In comparison to CD133low cells, CD133high cells also express higher levels of AdoHcyase, known to play a key role in the control of methylation [44] and that, in breast cancer, seems to be involved in regulation of histone methylation via the 2 member enhancer of zeste homolog 2 (EZH2) [39].